Cargando…

The advanced lung cancer inflammation index predicts chemotherapy response and infection risk in multiple myeloma patients receiving induction chemotherapy

Objective: This study aims to determine the clinical significance of the advanced lung cancer inflammation index (ALI) in predicting prognosis, chemotherapy response, and infection risk in newly diagnosed multiple myeloma (MM) patients receiving induction therapy. Methods: A retrospective analysis o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Jie, Li, Qianyuan, Xiao, Sheng, Nie, Lu, Liao, Jianping, Jiang, Qingjie, Xiang, Biyu, Zhang, Hongfei, Jiang, Yanhong, Yao, Chenjiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678942/ https://www.ncbi.nlm.nih.gov/pubmed/36425070 http://dx.doi.org/10.3389/fgene.2022.1047326

Ejemplares similares

VAD chemotherapy as remission induction for multiple myeloma.
por: Anderson, H., et al.
Publicado: (1995)

Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy
por: Pierga, J-Y, et al.
Publicado: (2007)

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
por: Zheng, Chen, et al.
Publicado: (2023)

Assessment and monitoring of patients receiving chemotherapy for multiple myeloma: strategies to improve outcomes
por: Faiman, Beth, et al.
Publicado: (2016)

Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents
por: Lee, Sung-Eun, et al.
Publicado: (2018)

In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2021)

Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
por: Dong, Jie, et al.
Publicado: (2021)

Receptor tyrosine kinases and schistosome reproduction: new targets for chemotherapy
por: Morel, Marion, et al.
Publicado: (2014)

Prognostic Autophagy-Related Genes of Gastric Cancer Patients on Chemotherapy
por: Liu, Xiaolong, et al.
Publicado: (2021)

CDH6 as a prognostic indicator and marker for chemotherapy in gliomas
por: Meng, Ming, et al.
Publicado: (2022)

Identification and validation of an immunological microenvironment signature and prediction model for epstein-barr virus positive lymphoma: Implications for immunotherapy
por: Yao, Chenjiao, et al.
Publicado: (2022)

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy
por: Lv, Jia‐Wei, et al.
Publicado: (2018)

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy
por: Versluis, Jurjen, et al.
Publicado: (2022)

LncRNAs could play a vital role in osteosarcoma treatment: Inhibiting osteosarcoma progression and improving chemotherapy resistance
por: Xiaotong, Shi, et al.
Publicado: (2023)

Prognostic Ferroptosis-Related lncRNA Signatures Associated With Immunotherapy and Chemotherapy Responses in Patients With Stomach Cancer
por: Lai, Donglin, et al.
Publicado: (2022)

Chemotherapy administration checklist for patients receiving chemotherapy: Development and validation
por: Miglani, Gitika, et al.
Publicado: (2022)

Multimodal Treatment Including Intracavitary Chemotherapy for Recurrent Pediatric Pleuropulmonary Blastoma
por: Habti, Merieme, et al.
Publicado: (2021)

A prognostic signature of pyroptosis-related lncRNAs verified in gastric cancer samples to predict the immunotherapy and chemotherapy drug sensitivity
por: Wang, Yanan, et al.
Publicado: (2022)

Corrigendum: Prognostic ferroptosis-related lncRNA signatures associated with immunotherapy and chemotherapy responses in patients with stomach cancer
por: Lai, Donglin, et al.
Publicado: (2022)

Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study
por: Zhang, Bin, et al.
Publicado: (2016)

Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?
por: Chollet, P, et al.
Publicado: (2003)

Genetic polymorphism in the NRF2 gene as a prognosis marker for cancer chemotherapy
por: Ishikawa, Toshihisa
Publicado: (2014)

Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines
por: Roell, Kyle R., et al.
Publicado: (2019)

Induction Chemotherapy Followed by Chemoradiotherapy With or Without Consolidation Chemotherapy Versus Chemoradiotherapy Followed by Consolidation Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Xiang, Mingyue, et al.
Publicado: (2022)

Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy
por: Iihara, Hirotoshi, et al.
Publicado: (2015)

Consolidation Chemotherapy Rather than Induction Chemotherapy Can Prolong the Survival Rate of Inoperable Esophageal Cancer Patients Who Received Concurrent Chemoradiotherapy
por: Xia, Xiaojie, et al.
Publicado: (2022)

Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma
por: Frias, Sara, et al.
Publicado: (2020)

Induction chemotherapy before autologous stem cell transplantation for symptomatic plasma cell myeloma – does it matter?
por: Fung, Henry C, et al.
Publicado: (2010)

Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
por: Liu, Pingping, et al.
Publicado: (2022)

Longitudinal assessment of pain management with the pain management index in cancer outpatients receiving chemotherapy
por: Fujii, Akiko, et al.
Publicado: (2016)

A Five-Gene Risk Score Model for Predicting the Prognosis of Multiple Myeloma Patients Based on Gene Expression Profiles
por: Chen, Xiaotong, et al.
Publicado: (2021)

Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma
por: Han, Xiaoyan, et al.
Publicado: (2017)

Telomere maintenance-related genes are important for survival prediction and subtype identification in bladder cancer
por: Xiao, Yonggui, et al.
Publicado: (2023)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

Simultaneous detection of genomic imbalance in patients receiving preimplantation genetic testing for monogenic diseases (PGT-M)
por: Yang, Lin, et al.
Publicado: (2022)

Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma
por: Johnstone, Megan, et al.
Publicado: (2022)

Galaxy and MEAN Stack to Create a User-Friendly Workflow for the Rational Optimization of Cancer Chemotherapy
por: Pires, Jorge Guerra, et al.
Publicado: (2021)

Comparison of TPF and TP Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma Based on TNM Stage and Pretreatment Systemic Immune-Inflammation Index
por: Xiong, Ying, et al.
Publicado: (2021)

A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy
por: Zhou, Hui, et al.
Publicado: (2023)

Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy
por: Kikuchi, Takaki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u3qbmb90uf0rcs2kil7m0j49ld